Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer

(2009) Yu-Ning Wong et al.   EUROPEAN UROLOGY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Duration of Androgen Suppression in the Treatment of Prostate Cancer

(2009) Michel Bolla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?

(2008) Matthew R. Smith et al.   BJU INTERNATIONAL

Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02

(2008) Jason A. Efstathiou et al.   EUROPEAN UROLOGY

Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer

(2008) Anthony V. D’Amico et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

(2008) Mack Roach et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31

(2008) Jason A. Efstathiou et al.   JOURNAL OF CLINICAL ONCOLOGY